EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Breaking the virus: Yeast glucans as an effective alternative to acyclovir in HSVI treatment

Diana Tavares-Valente, Helena Moreira, Pedro Sousa, Manuela Amorim, António Conde, Manuela Pintado, João Fernandes, João Azevedo-Silva

European Journal of Pharmaceutics and Biopharmaceutics · 2025

DOI: 10.1016/j.ejpb.2025.114684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2025. Verfasst von Diana Tavares-Valente und 7 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Bote…. Hauptthemen laut MEDLINE: Antiviral Agents, Acyclovir, Herpes Simplex, Glucans. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology, National Innovation Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucans, structural polysaccharides in the yeast cell wall, are known for their biological and immunomodulatory capacities, helping in prevention and management of infections. Herpes simplex virus type 1 (HSVI) is a prevalent infection that causes great comorbidity and is challenging to treat due to the adverse effects of standard antiviral drugs like acyclovir. This study assessed the potential of yeast glucans extracted from two different origins - a steviol-glycoside producing strain and a wild-type strain- to circumvent HSVI infection, either in vitro and ex vivo. Treatment with glucans in keratinocytes and macrophages in vitro reduced cell infection similarly to acyclovir. However, unlike acyclovir, glucans demonstrated an immunostimulatory effect, increasing the production of IL-1β, TNF-α and IL-6. Additionally, both glucans were formulated with squalane for skin application. This formulation improved glucans penetration in the skin, restored skin structure and reduced the cytopathic effect of HSVI infection. In summary, this study highlights yeast glucans as a natural therapeutic alternative for HSVI treatment, offering an option with an excellent safety profile. Moreover, using glucans from industrial side-streams promotes a sustainable approach, contributing to the circular economy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsAcyclovirHerpes SimplexGlucansHerpesvirus 1, HumanYeastsAnimalsHumansMiceKeratinocytesSaccharomyces cerevisiaeSkinMacrophagesRAW 264.7 Cells

Stichwörter der Autor:innen

Circular economyHSVI infectionImmune stimulationSkin ex vivo modelYeast Glucans

Substanzen

Antiviral AgentsAcyclovirGlucans

Autor:innen und Institutionen

  • Universidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal; Amyris Bio Products Portugal, Unip…
  • Universidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
  • Hospital Lusíadas, Av. da Boavista 171, 4050-115 Porto, Portugal.

Förderung

  • Foundation for Science and Technology
  • National Innovation Agency

Zitieren

APA

Tavares-Valente, D., Moreira, H., Sousa, P., Amorim, M., Conde, A., Pintado, M., Fernandes, J., & Azevedo-Silva, J. (2025). Breaking the virus: Yeast glucans as an effective alternative to acyclovir in HSVI treatment. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2025.114684

Vancouver

Tavares-Valente D, Moreira H, Sousa P, Amorim M, Conde A, Pintado M, et al. Breaking the virus: Yeast glucans as an effective alternative to acyclovir in HSVI treatment. European Journal of Pharmaceutics and Biopharmaceutics. 2025. doi:10.1016/j.ejpb.2025.114684

BibTeX
@article{TavaresValente2025,
  author = {Tavares-Valente, Diana and Moreira, Helena and Sousa, Pedro and Amorim, Manuela and Conde, António and Pintado, Manuela and Fernandes, João and Azevedo-Silva, João},
  title = {Breaking the virus: Yeast glucans as an effective alternative to acyclovir in HSVI treatment},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2025},
  doi = {10.1016/j.ejpb.2025.114684}
}
Kostenlos starten →